Figure 1.
Novel AML Targets and Therapies
Abbreviations: NEDD-8, neural precursor cell expressed, developmentally down-regulated 8-activating enzyme; IDH, isocitrate dehydrogenase; BCL2, B-cell Lymphoma 2; FLT3, fms like tyrosine kinase 3; CAR, chimeric antigen receptor; DART, dual-affinity re-targeting antibody.